MAPT and neurodegenerative disease: In the context of neurodegenerative diseases, proteostasis loss substentially contributes to the abnormal accumulation of various pathological proteins, including amyloid-beta (Aβ), hyperphosphorylated tau, α-synuclein (α-syn), TAR DNA binding protein-43 (TDP-43), huntingtin (HTT).